<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03537638</url>
  </required_header>
  <id_info>
    <org_study_id>PI15/01377</org_study_id>
    <nct_id>NCT03537638</nct_id>
  </id_info>
  <brief_title>Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE</brief_title>
  <official_title>Effectiveness and Cost-effectiveness of a Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With Systemic Lupus Erythematosus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Servicio Canario de Salud</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Servicio Canario de Salud</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Principal objective: To produce scientific knowledge on the effectiveness and
      cost-effectiveness of a multicomponent intervention for knowledge transfer and implementing a
      Clinical Practice Guideline (CPG) for Systemic Lupus Erythematosus (SLE), formed by an
      educative intervention, an computerized clinical decision support system (SADC), complemented
      by an automated feedback built into the electronic clinical record.

      Secondary objectives will be previously developed: 1) the analysis of medical practice
      variations along the care of SLE patients in the Canary Islands Health Service (SCS); 2) the
      best available scientific evidence to support the optimal development of the SADC; 3) the
      context and the barriers to innovation implementation in the SCS; and 4) the development of
      the contents for the implementation strategy, including the SADC and the automated feedback.

      Methods for the main objective: The main objective will be assessed under an open,
      multicentric and randomized (by clusters) clinical trial, in the SCS. The multicomponent
      intervention will be compared to the usual procedures for CPG dissemination. The main measure
      will be the self-perceived activity of SLE rated by the SLAQ scale. Self-perceived health
      related quality of life (HRQoL) data will be obtained by means of the questionnaire EQ-5D-5L
      , to estimate a cost-effectiveness ratio.

      Methods for secondary objectives: The rest of the objectives will be developed by a mix of
      quantitative and qualitative research methods to allow adapting the design, development and
      execution of the intervention to the characteristics of the context.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of self-perceived activity of the SLE</measure>
    <time_frame>18 months</time_frame>
    <description>Disease activity self-reported by the patient using the Systemic Lupus Erythematosus Activity (SLAQ) Questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in knowledge</measure>
    <time_frame>18 months</time_frame>
    <description>Acquired knowledges assessed by a questionnaire designed ad hoc</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in self-perceived health-related quality of life EQ-5D - 5L</measure>
    <time_frame>18 months</time_frame>
    <description>Self-perceived health-related quality of life using EQ-5D - 5L questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in patient's perception about clinician facilitation and decisiom-making process</measure>
    <time_frame>18 moths</time_frame>
    <description>Patient's perception of clinician facilitation and decision-making process using the Shared Decision-Making (SDM-Q-9) Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">418</enrollment>
  <condition>Systemic Lupus Erythematosus</condition>
  <arm_group>
    <arm_group_label>Multicomponent Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Rheumatologist and internist receive a multicomponent intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Rheumatologist and internist provide the usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Multicomponent intervention</intervention_name>
    <description>Intervention to rheumatologist and internist responsible for the care of patients with SLE. Implementation multicomponent intervention consisting of: educational component, a computerized clinical decision support system developed from the clinical practice guide - SLE and automated feedback integrated into the electronic medical record system.</description>
    <arm_group_label>Multicomponent Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients:

        Adults (older than 18 years) diagnosed with SLE of any seriousness and situation (active,
        remission or clinically quiescent and serologically active), who agree to participate and
        sign informed consent.

          -  Health professionals:

        Physicians specialized in rheumatology or internal medicine that include in their quotas a
        minimum of 30 patients with eligible SLE.

        Exclusion Criteria:

          -  Patients:

        SLE limited to the skin, advanced chronic kidney disease (dialysis or renal transplant);
        Mental illnesses and / or sensory or cognitive deficits; or participating in extension or
        follow-up studies of another RCT (possible change in follow-up guidelines). Participants in
        observational studies may be included as they do not change usual practice.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>María de Mar Trujillo Martin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Servicio de Evaluación del Servicio Canario de la Salud</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>María de Mar Trujillo Martin, PhD</last_name>
    <phone>+34 922 684019</phone>
    <phone_ext>209</phone_ext>
    <email>mar.trujillomartin@sescs.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yolanda Ramallo Fariña</last_name>
    <phone>+34 922 684019</phone>
    <email>yolanda.ramallofarina@sescs.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Servicio de Evaluación del Servicio Canario de la Salud</name>
      <address>
        <city>Santa Cruz de Tenerife</city>
        <zip>38004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María del Mar Trujillo Martín, PhD</last_name>
      <phone>+34 922 684019</phone>
      <phone_ext>209</phone_ext>
      <email>mar.trujillomartin@sescs.es</email>
    </contact>
    <investigator>
      <last_name>María del Mar Trujillo Martín, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yolanda Ramallo Fariña</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Vallejo Torres, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pilar García Sagredo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Iñaki Imaz Iglesia, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roberto Martín Fernández</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Iñigo Rúa-Figueroa Fernández de Larrinoa, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana María Pascual</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisa Trujillo Martín, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose Angel Hernández Beriain, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Casas Hernández, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Serrano-Aguilar P, Kovacs FM, Cabrera-Hernández JM, Ramos-Goñi JM, García-Pérez L. Avoidable costs of physical treatments for chronic back, neck and shoulder pain within the Spanish National Health Service: a cross-sectional study. BMC Musculoskelet Disord. 2011 Dec 21;12:287. doi: 10.1186/1471-2474-12-287.</citation>
    <PMID>22188790</PMID>
  </reference>
  <reference>
    <citation>Østbye T, Yarnall KS, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med. 2005 May-Jun;3(3):209-14.</citation>
    <PMID>15928223</PMID>
  </reference>
  <reference>
    <citation>Zhu TY, Tam LS, Li EK. Cost-of-illness studies in systemic lupus erythematosus: A systematic review. Arthritis Care Res (Hoboken). 2011 May;63(5):751-60. doi: 10.1002/acr.20410. Review. Erratum in: Arthritis Care Res (Hoboken). 2011 Jul;63(7):1074.</citation>
    <PMID>21557530</PMID>
  </reference>
  <reference>
    <citation>Lerang K, Gilboe IM, Gran JT. Differences between rheumatologists and other internists regarding diagnosis and treatment of systemic lupus erythematosus. Rheumatology (Oxford). 2012 Apr;51(4):663-9. doi: 10.1093/rheumatology/ker318. Epub 2011 Dec 7.</citation>
    <PMID>22157467</PMID>
  </reference>
  <reference>
    <citation>Bertsias G, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C, Font J, Gilboe IM, Houssiau F, Huizinga T, Isenberg D, Kallenberg CG, Khamashta M, Piette JC, Schneider M, Smolen J, Sturfelt G, Tincani A, van Vollenhoven R, Gordon C, Boumpas DT; Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis. 2008 Feb;67(2):195-205. Epub 2007 May 15.</citation>
    <PMID>17504841</PMID>
  </reference>
  <reference>
    <citation>Sidorenkov G, Haaijer-Ruskamp FM, de Zeeuw D, Denig P. A longitudinal study examining adherence to guidelines in diabetes care according to different definitions of adequacy and timeliness. PLoS One. 2011;6(9):e24278. doi: 10.1371/journal.pone.0024278. Epub 2011 Sep 8.</citation>
    <PMID>21931669</PMID>
  </reference>
  <reference>
    <citation>Perez X, Wisnivesky JP, Lurslurchachai L, Kleinman LC, Kronish IM. Barriers to adherence to COPD guidelines among primary care providers. Respir Med. 2012 Mar;106(3):374-81. doi: 10.1016/j.rmed.2011.09.010. Epub 2011 Oct 13.</citation>
    <PMID>22000501</PMID>
  </reference>
  <reference>
    <citation>Kastner M, Bhattacharyya O, Hayden L, Makarski J, Estey E, Durocher L, Chatterjee A, Perrier L, Graham ID, Straus SE, Zwarenstein M, Brouwers M. Guideline uptake is influenced by six implementability domains for creating and communicating guidelines: a realist review. J Clin Epidemiol. 2015 May;68(5):498-509. doi: 10.1016/j.jclinepi.2014.12.013. Epub 2015 Jan 10. Review.</citation>
    <PMID>25684154</PMID>
  </reference>
  <reference>
    <citation>Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999 Oct 20;282(15):1458-65. Review.</citation>
    <PMID>10535437</PMID>
  </reference>
  <reference>
    <citation>Jacobs SR, Weiner BJ, Bunger AC. Context matters: measuring implementation climate among individuals and groups. Implement Sci. 2014 Apr 17;9:46. doi: 10.1186/1748-5908-9-46.</citation>
    <PMID>24742308</PMID>
  </reference>
  <reference>
    <citation>Francke AL, Smit MC, de Veer AJ, Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak. 2008 Sep 12;8:38. doi: 10.1186/1472-6947-8-38. Review.</citation>
    <PMID>18789150</PMID>
  </reference>
  <reference>
    <citation>Grimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE. Knowledge translation of research findings. Implement Sci. 2012 May 31;7:50. doi: 10.1186/1748-5908-7-50.</citation>
    <PMID>22651257</PMID>
  </reference>
  <reference>
    <citation>Sketris IS, Langille Ingram EM, Lummis HL. Strategic opportunities for effective optimal prescribing and medication management. Can J Clin Pharmacol. 2009 Winter;16(1):e103-25. Epub 2009 Jan 30. Review.</citation>
    <PMID>19182305</PMID>
  </reference>
  <reference>
    <citation>Giguère A, Légaré F, Grimshaw J, Turcotte S, Fiander M, Grudniewicz A, Makosso-Kallyth S, Wolf FM, Farmer AP, Gagnon MP. Printed educational materials: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012 Oct 17;10:CD004398. doi: 10.1002/14651858.CD004398.pub3. Review.</citation>
    <PMID>23076904</PMID>
  </reference>
  <reference>
    <citation>Shojania KG, Jennings A, Mayhew A, Ramsay CR, Eccles MP, Grimshaw J. The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD001096. doi: 10.1002/14651858.CD001096.pub2. Review.</citation>
    <PMID>19588323</PMID>
  </reference>
  <reference>
    <citation>Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, Robertson N. Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD005470. doi: 10.1002/14651858.CD005470.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;4:CD005470.</citation>
    <PMID>20238340</PMID>
  </reference>
  <reference>
    <citation>Gillaizeau F, Chan E, Trinquart L, Colombet I, Walton RT, Rège-Walther M, Burnand B, Durieux P. Computerized advice on drug dosage to improve prescribing practice. Cochrane Database Syst Rev. 2013 Nov 12;(11):CD002894. doi: 10.1002/14651858.CD002894.pub3. Review.</citation>
    <PMID>24218045</PMID>
  </reference>
  <reference>
    <citation>Murphy EV. Clinical decision support: effectiveness in improving quality processes and clinical outcomes and factors that may influence success. Yale J Biol Med. 2014 Jun 6;87(2):187-97. eCollection 2014 Jun. Review.</citation>
    <PMID>24910564</PMID>
  </reference>
  <reference>
    <citation>Ramallo-Fariña Y, García-Pérez L, Castilla-Rodríguez I, Perestelo-Pérez L, Wägner AM, de Pablos-Velasco P, Domínguez AC, Cortés MB, Vallejo-Torres L, Ramírez ME, Martín PP, García-Puente I, Salinero-Fort MÁ, Serrano-Aguilar PG; INDICA team. Effectiveness and cost-effectiveness of knowledge transfer and behavior modification interventions in type 2 diabetes mellitus patients--the INDICA study: a cluster randomized controlled trial. Implement Sci. 2015 Apr 9;10:47. doi: 10.1186/s13012-015-0233-1.</citation>
    <PMID>25880498</PMID>
  </reference>
  <reference>
    <citation>Roshanov PS, Fernandes N, Wilczynski JM, Hemens BJ, You JJ, Handler SM, Nieuwlaat R, Souza NM, Beyene J, Van Spall HG, Garg AX, Haynes RB. Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ. 2013 Feb 14;346:f657. doi: 10.1136/bmj.f657.</citation>
    <PMID>23412440</PMID>
  </reference>
  <reference>
    <citation>Lobach D, Sanders GD, Bright TJ, Wong A, Dhurjati R, Bristow E, Bastian L, Coeytaux R, Samsa G, Hasselblad V, Williams JW, Wing L, Musty M, Kendrick AS. Enabling health care decisionmaking through clinical decision support and knowledge management. Evid Rep Technol Assess (Full Rep). 2012 Apr;(203):1-784. Review.</citation>
    <PMID>23126650</PMID>
  </reference>
  <reference>
    <citation>Hoffmann TC, Montori VM, Del Mar C. The connection between evidence-based medicine and shared decision making. JAMA. 2014 Oct 1;312(13):1295-6. doi: 10.1001/jama.2014.10186.</citation>
    <PMID>25268434</PMID>
  </reference>
  <reference>
    <citation>Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, Cording E, Tomson D, Dodd C, Rollnick S, Edwards A, Barry M. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012 Oct;27(10):1361-7. Epub 2012 May 23. Review.</citation>
    <PMID>22618581</PMID>
  </reference>
  <reference>
    <citation>Serrano-Aguilar P, Trujillo-Martin Mdel M, Pérez de la Rosa A, Cuellar-Pompa L, Saavedra-Medina H, Linertova R, Perestelo-Perez L, Perez-Ramos J, Rivero-Santana A; Spanish SLE CPG Development Group. Patient participation in a Clinical Guideline Development for Systemic Lupus Erythematosus. Patient Educ Couns. 2015 Sep;98(9):1156-63. doi: 10.1016/j.pec.2015.05.022. Epub 2015 Jun 11. Review.</citation>
    <PMID>26095343</PMID>
  </reference>
  <reference>
    <citation>Politi MC, Wolin KY, Légaré F. Implementing clinical practice guidelines about health promotion and disease prevention through shared decision making. J Gen Intern Med. 2013 Jun;28(6):838-44. doi: 10.1007/s11606-012-2321-0. Epub 2013 Jan 10. Review.</citation>
    <PMID>23307397</PMID>
  </reference>
  <reference>
    <citation>Loya SR, Kawamoto K, Chatwin C, Huser V. Service oriented architecture for clinical decision support: a systematic review and future directions. J Med Syst. 2014 Dec;38(12):140. doi: 10.1007/s10916-014-0140-z. Epub 2014 Oct 18. Review.</citation>
    <PMID>25325996</PMID>
  </reference>
  <reference>
    <citation>Panzarasa S, et al.Technical Solutions for Integrating Clinical Practice Guidelines with Electronic Patient Records. Volume 5943 of LNAI. Springer-Verlag 2010;141 -154</citation>
  </reference>
  <reference>
    <citation>Kawamoto K, Del Fiol G, Orton C, Lobach DF. System-agnostic clinical decision support services: benefits and challenges for scalable decision support. Open Med Inform J. 2010;4:245-54. doi: 10.2174/1874431101004010245. Epub 2010 Dec 14.</citation>
    <PMID>21603281</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2018</study_first_submitted>
  <study_first_submitted_qc>May 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2018</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lupus</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Multicomponent intervention</keyword>
  <keyword>Clinical Practice Guideline</keyword>
  <keyword>Computerized clinical decision support system</keyword>
  <keyword>Activity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

